Global Cell Therapy Market: Industry Analysis and Forecast (2020-2026) by Therapy Type, Cell Type, Applications, End-Users and Region

Global Cell Therapy Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 14.8% during the forecast period.

Global Cell Therapy Market Overview:

Cell therapy is the introduction of viable cells into a patient’s body in order to grow, replace or repair damaged tissue in order to treat a disease. For example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Global Cell Therapy Market Dynamics:

Technological advancements in the medical field and rise in number of clinical studies are the primary factors driving the market growth. The rising incidence of chronic and infectious diseases is the vital factor escalating the market growth. Also, the rise in adoption of human cells for cell therapeutics research, technological advancements in the field of cell therapy, and the increase in adoption of regenerative medicine contribute to the market growth. The surge in the number of regulations to promote stem cell therapy and increase in funds for research in developing countries are expected to offer lucrative opportunities for the market in the future. Apart from this, the demand for precision medicine in the field of oncology where a patient receives personalized treatment creates potential opportunities for the cell therapy market growth. However, certain factors like the increased cost of cell-based research and the rising dearth of skilled professionals may hamper the market growth. The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Cell Therapy Market Segment Analysis:

The global Cell Therapy Market is segmented on the basis of Therapy Type, Cell type, Application and End-Users. Based on Therapy Type, the autologous therapy segment dominated the market in 2020 and is expected to maintain dominance throughout the forecast period. This can be attributed to several advantages associated with autologous transplants such as easy availability, no need to identify an HLA-matched donor, lower risk of life-threatening complications, no risk of GVHD, and no necessity of immunosuppressive therapy. In addition, autologous therapies are affordable when compared to allogeneic therapies which can be further attributed to segment growth. Based on Cell Type, the stem cell segment contributed the largest share of the global cell therapy market in 2019 and is expected to retain its dominance during forecast years. The segment growth is accounted due to an increase in awareness regarding the storage of stem cells and the growing number of stem cell banks in the developing nations have a positive impact on market growth. Global Cell Therapy Market To know about the Research Methodology :- Request Free Sample Report

Global Cell Therapy Market Regional Insights:

Global Cell Therapy Market by Regional North America held dominant market share in 2020 and is expected to continue the dominance throughout the forecast period. North America market is anticipated to hold prominent market share owing to the increasing incidence of target diseases like cancer and rising demand for its advanced treatment other than chemotherapy. Also, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region augment the market growth in the region.

Asia Pacific is expected to witness lucrative growth during forecast period.

Asia-Pacific exhibits high potential for growth in the market owing to a high patient pool due to large population in many countries. Moreover, developing countries such as India and China are expected to experience growth, owing to surge in healthcare infrastructure, increase in affordability, and rise in awareness related to cell therapy. The report also helps in understanding Global Cell Therapy Market dynamics, structure by analyzing the market segments and project the Global Cell Therapy Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Cell Therapy Market make the report investor’s guide.

Key Developments:

In August 2019, Bayer AG, a Germany-based pharmaceutical and life sciences company, acquired BlueRock Therapeutics, an engineered cell therapy company, for $1 billion. Through this transaction, Bayer AG will acquire complete BlueRock Therapeutics' CELL+GENE platform, including a broad intellectual property portfolio and associated technology platform including proprietary iPSC technology, gene engineering, and cell differentiation capabilities.

COVID-19 Impact:

According to the report by the UK’s Cell and Gene Therapy (CGT) Catapult – a center of excellence for the cell and gene therapy industry, states that despite the tremendous impact of COVID-19 on many industries, the number of advanced therapy medicinal product (ATMP) clinical trials continued to grow in 2020. Covid-19 has made biopharmaceutical reformers across the world come forward in response to the pandemic which, in turn, has impacted the global cell therapy market positively.

Global Cell Therapy Market Scope: Inquire before buying

Global Cell Therapy Market by Scope

Global Cell Therapy Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Cell Therapy Market, Key Players:

• Kolon TissueGene, Inc. • Anterogen Co., Ltd. • JCR Pharmaceuticals Co., Ltd. • Castle Creek Biosciences, Inc. • The Future of Biotechnology, MEDIPOST • Osiris Therapeutics, Inc. • PHARMICELL Co., Ltd • Tameika Cell Technologies, Inc. • Cells for Cells • NuVasive, Inc. • Vericel Corporation • Celgene Corporation • Thermo Fisher Scientific Inc. • Merck KGaA • Danaher Corporation • Becton, Dickinson and Company • Lonza Group • Sartorius AG • Terumo BCT • Fresenius Medical Care AG & Co. KGaA
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cell Therapy Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Cell Therapy Market 3.4. Geographical Snapshot of the Cell Therapy Market, By Manufacturer share 4. Global Cell Therapy Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Cell Therapy Market 5. Supply Side and Demand Side Indicators 6. Global Cell Therapy Market Analysis and Forecast, 2019-2026 6.1. Global Cell Therapy Market Size & Y-o-Y Growth Analysis. 7. Global Cell Therapy Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 7.1.1. Autologous 7.1.2. Allogeneic 7.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 7.2.1. T-cells 7.2.2. Stem Cells 7.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.3.1. Malignancies 7.3.2. Musculoskeletal Disorders 7.3.3. Autoimmune Disorders 7.3.4. Dermatology 7.3.5. Others 7.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 7.4.1. Hospitals & Clinics 7.4.2. Academic & Research Institutes 8. Global Cell Therapy Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Cell Therapy Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 9.1.1. Autologous 9.1.2. Allogeneic 9.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 9.2.1. T-cells 9.2.2. Stem Cells 9.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.3.1. Malignancies 9.3.2. Musculoskeletal Disorders 9.3.3. Autoimmune Disorders 9.3.4. Dermatology 9.3.5. Others 9.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 9.4.1. Hospitals & Clinics 9.4.2. Academic & Research Institutes 10. North America Cell Therapy Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Cell Therapy Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 11.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 12. Canada Cell Therapy Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 13. Mexico Cell Therapy Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 14. Europe Cell Therapy Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 15. Europe Cell Therapy Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Cell Therapy Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 16.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 17. France Cell Therapy Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 18. Germany Cell Therapy Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 19. Italy Cell Therapy Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 20. Spain Cell Therapy Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 21. Sweden Cell Therapy Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 22. CIS Countries Cell Therapy Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 23. Rest of Europe Cell Therapy Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 24. Asia Pacific Cell Therapy Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 25. Asia Pacific Cell Therapy Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Cell Therapy Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 26.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 27. India Cell Therapy Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 28. Japan Cell Therapy Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 29. South Korea Cell Therapy Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 30. Australia Cell Therapy Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 31. ASEAN Cell Therapy Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 32. Rest of Asia Pacific Cell Therapy Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 33. Middle East Africa Cell Therapy Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 34. Middle East Africa Cell Therapy Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Cell Therapy Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 35.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 36. GCC Countries Cell Therapy Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 37. Egypt Cell Therapy Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 38. Nigeria Cell Therapy Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 39. Rest of ME&A Cell Therapy Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 40. South America Cell Therapy Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 41. South America Cell Therapy Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Cell Therapy Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 42.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 43. Argentina Cell Therapy Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 44. Rest of South America Cell Therapy Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Therapy Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Cell Type, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Cell Therapy Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Kolon TissueGene, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Anterogen Co., Ltd. 45.3.3. JCR Pharmaceuticals Co., Ltd. 45.3.4. Castle Creek Biosciences, Inc. 45.3.5. Osiris Therapeutics, Inc. 45.3.6. PHARMICELL Co., Ltd 45.3.7. Tameika Cell Technologies, Inc. 45.3.8. NuVasive, Inc. 45.3.9. Vericel Corporation 45.3.10. Celgene Corporation 45.3.11. Thermo Fisher Scientific Inc. 45.3.12. Merck KGaA 45.3.13. Danaher Corporation 45.3.14. Becton, Dickinson and Company 45.3.15. Lonza Group 45.3.16. Sartorius AG 45.3.17. Terumo BCT 45.3.18. Fresenius Medical Care AG & Co. KGaA 46. Primary Key Insights

About This Report

Report ID94726
Category Medical Devices
Published DateApril 2021
Updated DateOct 2021
Contact Us